日期: 2026年3月16日
伊朗战争占据地区关注与全球焦点之际，哈马斯重新掌控加沙
(SeaPRwire) - 社交媒体上流传的视频和照片显示，随着与伊朗的战争占据该地区的关注焦点，哈马斯正悄然重新巩固对加沙地带的控制。一名以色列分析人士和一名加沙政治评论员表示，这些动态引发了新的质疑——有关加沙战后安排的计划能否在短期内推进。特拉维夫大学戴扬中心高级分析师迈克尔·米尔施泰因（Michael Milshtein）表示，过去两周半时间里，哈马斯不仅在军事上进行了恢复，还在公共生活中展现了可见的控制权。米尔施泰因描述了加沙中部出现的新招募人员、警察部署甚至游行活动，他说：“他们确实充分利用这段时间在公共领域确立权力，而不仅仅是军事恢复。哈马斯将长期存在。”他表示，加沙民众报告称，哈马斯还在重建治理机制。“他们的警察无处不在，”他说，“他们还在完善税收体系。”他补充说，在斋月期间，哈马斯人员检查市场和清真寺，并“开始构建教育体系”。加沙政治分析师穆海默尔·阿布·萨达（Mukhaimer Abu Saada）认同，自伊朗战争升级以来，加沙战后规划的势头已基本停滞。“所有与加沙相关的事务都被搁置了，”阿布·萨达向Digital表示。他说，在这场地区战争爆发前，相关进展曾“朝着正确方向推进”，包括围绕和平委员会、加沙技术委员会的工作，以及与可能的国际稳定部队相关的讨论。“是的，哈马斯利用了当前局势，”阿布·萨达说，“他们不再像以前那样面临压力。”两位分析人士都指出了同一大趋势：随着关注焦点转向伊朗，对哈马斯的压力有所缓解。阿布·萨达表示，战前曾有他所说的关于解除武装、部署国际部队和加沙政治未来的严肃讨论。但“战前的热情已经降温”，他补充说，加沙已被推至“次要位置”。“当我与巴勒斯坦人交谈时，他们告诉我，‘听着，我们实际上已经在等待战争结束后的那一天，’”米尔施泰因说。他表示，一些人预计内塔尼亚胡（Netanyahu）将因伊朗战争“对特朗普（Trump）非常感激，他将不得不接受特朗普对加沙的任何指令”。这些讨论的核心是国际稳定部队进入加沙的可能性。但两人都暗示，哈马斯可能不将这样一支部队视为威胁。阿布·萨达表示，哈马斯“欢迎部署”这样的部队，并似乎将其视为“约束以色列军队”而非“来解除该组织武装”的力量。他说，来自印尼等国的部队参与可能使这种部署对哈马斯显得威胁较小，哈马斯可能将其视为抵御以色列持续军事行动的缓冲。米尔施泰因进一步阐述这一观点，称哈马斯将这一模式更多视为黎巴嫩真主党与联合国驻黎巴嫩临时部队（UNIFIL）安排的翻版，而非维和任务。“哈马斯说，‘我没问题，这会像黎巴嫩的联合国驻黎巴嫩临时部队（UNIFIL）一样，’”米尔施泰因说，“别想追捕我们、收缴武器或进入隧道。你们也需要保护我们免受以色列侵害。”阿布·萨达表示，下一阶段的走向在很大程度上取决于伊朗战争的结局。他说，如果伊朗政权幸存并避免崩溃，哈马斯将从这一结果中获得鼓舞。“如果伊朗未被击败，如果伊朗政权没有崩溃，这将对哈马斯形成某种精神支持，”他说。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
据称与伊朗有关联的新恐怖组织宣称对欧洲四起袭击事件负责
(SeaPRwire) - 上周，一个涉嫌与伊朗政权有关联的新恐怖组织在欧洲出现。Harakat Ashab al-Yamin al-Islamiyya（The Islamic Movement of the Companions of the Right）已宣称对欧洲大陆多地的四起针对犹太目标的袭击负责。比利时列日的一座犹太教堂是周一爆炸袭击的首个目标。周五夜间，鹿特丹一座犹太教堂遭遇纵火袭击；次日傍晚，阿姆斯特丹一所犹太学校发生爆炸装置爆炸事件。多个消息来源将周三希腊一处犹太场所发生的另一起袭击与该组织关联起来，但未提供袭击目标或方式的具体细节。Joe Truzman（民主防御基金会高级研究分析师、FDD’s Long War Journal编辑）告诉Digital，当他看到该组织在周一袭击后发布的声明时，他“觉得有点业余”。Truzman表示，在该组织的视频开始出现后，他“意识到这个组织可能还有更多内幕”。他称，伊朗境内的战争很可能“迫使这个组织（无论幕后黑手是谁）开始发动这些袭击”。Truzman表示，他“怀疑这个组织是被人指使的”，且“背后有一个实体”。Truzman称，他怀疑是伊朗伊斯兰革命卫队（IRGC）本身所为，他表示该卫队“在欧洲一直很活跃”，并“试图消灭或暗杀异见人士”。不过他也不排除该组织是伊拉克民兵组织下属实体的可能性。除了预计Ashab al-Yamin会发动更多袭击外，Truzman还表示，他担心“（恐怖）视频在网上传播可能会迫使欧洲其他人实施反犹太袭击”。据Truzman称，Ashab al-Yamin的视频“开始受到关注，开始有了浏览量，人们正在看到这些视频。也许那些已经激进化或即将激进化的人，可能会受到这些视频的影响，进而实施反犹太袭击或针对犹太场所的袭击”。他表示，这些袭击“大多比较简陋，但情况可能会改变，他们可能会开始在白天繁忙时段针对人群”。截至目前，所有袭击都发生在夜间。以色列外交部在X平台发文称，该组织与德黑兰政权有关联。“一个与伊朗代理人有关联的圣战组织”应对这一系列袭击负责。他们指出，“伊朗伊斯兰革命卫队（IRGC）继续在全球范围内资助和输出恐怖主义”。观察人士越来越多地将这些袭击与伊朗境内的战争联系起来。世界犹太人大会（World Jewish Congress）在X平台上对Ashab al-Yamin发出警告，称“安全分析师认为，该组织可能是伊朗不断扩大的代理人网络的一部分，其活动范围远超出中东地区”。该大会呼吁各国政府“认真对待这一威胁，摧毁这些袭击背后的网络，确保犹太社区能够安全生活和礼拜”。以色列散居事务部长Amichai Chikli称这些袭击是“令人不安的模式的一部分”。他解释说，“与伊朗轴心有关联的恐怖网络正试图将其活动范围扩大到欧洲城市和犹太社区”。美国国务院未回应有关其是否此前一直在追踪Ashab al-Yamin，或是否计划向出国旅行的美国人发出警告以避开犹太机构的问题，但美国驻荷兰大使馆周一发布的警报警告称：“继荷兰及其他欧洲主要城市近期发生针对性爆炸事件后，美国驻荷兰使团提醒美国公民保持良好的个人安全习惯，并提高情境意识，这与美国国务院近期发布的《全球谨慎警报》一致。”该警报补充道：“正如《荷兰旅行建议》中所指出的，恐怖组织仍在策划在荷兰发动可能的袭击。恐怖分子可能在几乎没有或完全没有预警的情况下发动袭击，目标包括旅游景点、交通枢纽、市场/购物中心、地方政府设施、酒店、俱乐部、餐厅、礼拜场所、公园、大型体育和文化活动、教育机构、机场及其他公共区域。”以色列国家安全委员会近期警告其出国旅行的公民，要隐藏可能表明其为以色列人或犹太人的物品，并“避免前往被认定为犹太或以色列的场所”——这是在3月初多伦多犹太教堂发生三起枪击案的第一起之后发出的警告。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
特朗普警告北约盟友，若不协助确保霍尔木兹海峡安全，未来“形势将极为严峻”
(SeaPRwire) - 美国总统唐纳德·特朗普周日向北大西洋公约组织（NATO）发出了迄今最明确的警告：要么与美国一起捍卫霍尔木兹海峡，要么面临“非常糟糕”的未来。特朗普周日在接受《金融时报》（The Financial Times）采访时表示：“那些受益于该海峡的国家理应帮忙确保那里不发生坏事。如果没有回应，或者回应是否定的，我认为这对北约的未来将非常不利。”周日晚，特朗普从海湖庄园（Mar-a-Lago）度周末返回华盛顿特区，在“空军一号”（Air Force One）上的记者团采访中重申了这些言论，称“若有其他国家与我们一起巡逻那里会很好，我们会提供帮助——我们会在军事上合作。”特朗普对记者说：“记住，比如在很多情况下，北约国家有需要时，我们总是在那里支持北约，”他提到“帮助他们应对乌克兰问题”，尽管“对我们来说，这其实不影响我们。”“但我们还是帮了他们，”他补充道，并重申了去年秋天在联合国大会（United Nations General Assembly）上的言论，质疑北约是否会“始终在我们需要时支持我们”。特朗普正在寻求北约盟国的协助，为全球保障通过霍尔木兹海峡的油轮交通安全。特朗普政府官员一直在强调，在特朗普领导下，美国是石油净出口国，仅从中东获取少量石油——这与包括北约盟国在内的世界其他地区不同。特朗普在“空军一号”上对记者补充道：“看看哪个国家不愿帮我们完成这么小的任务——只是保持海峡开放，相比之下这是个小要求，这会很有意思。之所以说小，是因为伊朗的火力非常有限。”特朗普仍乐观地认为，北约盟国最终会加入。特朗普在“空军一号”（AF1）上对记者说：“我们正在与其他国家商谈合作巡逻海峡事宜，我认为我们得到了良好的回应。如果合作，那就太好了；如果不合作，也没关系。”长期以来，北约一直是特朗普的争议点，在其第一任期内，他不得不反复呼吁成员国达到国内生产总值（GDP）2%的国防开支门槛。现任特朗普政府驻北约大使马特·惠特克（Matt Whitaker）称赞第二届政府促使北约承诺将GDP的5%用于国防开支。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
THERMAL-XR(R) Sales in the United States to Commence After GMG Receives U.S. EPA Approval
Brisbane, Australia--(ACN Newswire via SeaPRwire.com. - March 16, 2026) - Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to announce that the United States Environmental Protection Agency ("EPA") has now approved the import and sale of GMG's THERMAL-XR graphene based coating system in the United States.The EPA has issued a consent order for pre-manufacture notice PMN P-25-0018 in accordance with section 5(e) of the Toxic Substances Control Act, 15 U.S.C. 2604(e) (the "Order"). Under the Order, GMG is authorised to export, distribute, sell, use and dispose of the chemical substance described in the pre-manufacture notice submitted by the Company, and which is used in GMG's THERMAL-XR® ENHANCE graphene-based coating system for various applications including Heating Venting Air Conditioning and Refrigeration (HVAC-R), Data Centres, Liquified Natural Gas Plants (LNG), Automotive and Electronics amongst others in the United States in accordance with the requirements and conditions set out in the Order (the "New Chemical Substance").GMG supplies its THERMAL-XR® graphene coating product for the HVAC-R equipment market to its exclusive North American distributor, Nu-Calgon Wholesaler, Inc. ("Nu-Calgon") which is marketed and sold as "Nu-Calgon CoolWorx® powered by GMG® Graphene" as seen in an example shown in Figure 1. As a result of the Order, GMG, together with Nu-Calgon, is now able to commence commercial sales of THERMAL-XR® products into the U.S. for industrial use, subject to and in accordance with the requirements and conditions of the Order.Figure 1: Nu-Calgon CoolWorx® Powered by GMG® Graphene LabelTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/288616_ab987720443d2967_001full.jpgThe first shipment of THERMAL-XR® will now be sent to Nu-Calgon for distribution in North America.Craig Nicol, CEO & Managing Director of the Company, commented, "We believe that this EPA consent order is a major milestone for GMG as it allows us, together with our exclusive North American distributor Nu-Calgon, to commence commercial sales of THERMAL-XR® in we what we see as the largest HVAC-R coating market in the world."Jack Perkowski, Chairman and Non-Executive Director of the Company, commented: "With regulatory clearance now in place, we believe that we can begin converting the strong interest that we have seen from customers into revenue, while leveraging Nu-Calgon's extensive distribution network to reach across the North America to scale THERMAL-XR® ENHANCE / CoolWorx® deployment over time. We believe that GMG is one of the few companies to have received EPA approval for the export and sale of an unlimited amount of a graphene-based product in the United States of America."About THERMAL-XR® ENHANCE powered by GMG Graphene:THERMAL-XR® ENHANCE coating system is a unique method of improving the conductivity of corroded heat exchange surfaces and improving and maintaining the performance of new units at peak levels. The process coats and protects heat exchange surfaces while improving and rebuilding the lost corroded thermal conductivity and increasing the heat transfer rate by leveraging the physics of GMG Graphene, resulting in an efficiency improvement and a potential power reduction.THERMAL-XR® ENHANCE is now patented for 20 years in Australia and is expected to be patented in other countries around the world.THERMAL-XR® ENHANCE Development and EPA Approval HistoryMonthSignificant Milestones for THERMAL-XR® powered by GMG GrapheneSeptember2022GMG acquires THERMAL-XR® manufacturing intellectual property and brand rights GMG ACQUIRES THERMAL-XR MANUFACTURING INTELLECTUAL PROPERTY AND BRAND RIGHTS AND GRANTS RSUs TO DIRECTORS AND OFFICERS - Graphene Manufacturing Group | GMG (graphenemg.com)December2022Verified Improved Heat Transfer by The University of Queensland. VERIFIED IMPROVED HEAT TRANSFER ON ALUMINIUM WITH THERMAL-XR® & MARKET UPDATE - Graphene Manufacturing Group | GMG (graphenemg.com)February2023Approval from Australian Industrial Chemicals Introduction Scheme (AICIS) GMG RECEIVES REGULATORY APPROVAL TO ENABLE SIGNIFICANT COMMERCIAL SALES - Graphene Manufacturing Group | GMG (graphenemg.com)April 2023Total available market for THERMAL-XR® estimated by Company to be > US$28.4 billion GMG ANNOUNCES COMMERCIALISATION PROGRESS OF THERMAL-XR® - Graphene Manufacturing Group | GMG (graphenemg.com)April 2023First order of THERMAL-XR® > $120,000 GMG ANNOUNCES COMMERCIALISATION PROGRESS OF THERMAL-XR® - Graphene Manufacturing Group | GMG (graphenemg.com)May 2023Signing of Distributors for Singapore, Thailand, Indonesia & South Korea GMG SIGNS THERMAL-XR® DISTRIBUTOR AGREEMENTS IN 4 ASIAN COUNTRIES - Graphene Manufacturing Group | GMG (graphenemg.com)June 2023Independently Verified Heat Transfer & Energy Savings GMG ANNOUNCES INDEPENDENTLY VERIFIED HEAT TRANSFER AND ENERGY SAVINGS RESULTS FROM THERMAL-XR® - Graphene Manufacturing Group | GMG (graphenemg.com)July 2023Signing of Nu-Calgon Distribution for North America - USA, Canada, Mexico, & Caribbean. GMG APPOINTS NU-CALGON AS THERMAL-XR® DISTRIBUTOR FOR NORTH AMERICA - Graphene Manufacturing Group | GMG (graphenemg.com)August2023Commissioning of THERMAL-XR® Coating Bulk Blend Plant GMG PROVIDES COMMERCIALISATION PROGRESS OF THERMAL-XR® - Graphene Manufacturing Group | GMG (graphenemg.com)October2023Forward Orders > AU$ 400k - Conditional on Import Approvals for some Countries GMG PROVIDES COMMERCIALISATION UPDATE ON ENERGY SAVINGS COATING THERMAL-XR® - Graphene Manufacturing Group | GMG (graphenemg.com)December2023Commissioning of the modular Graphene Production plant Graphene Manufacturing Group Commissions Modular Graphene Production Plant - Graphene Manufacturing Group | GMG (graphenemg.com)January2024Canada Approval Department of Environment and Climate Change Canada (ECCC)January2024Launch of Nu-Calgon CoolWorx® powered by GMG Graphene at Chicago AHR Expo 2024. Launch of Nu-Calgon CoolWorx® powered by GMG Graphene at Chicago AHR Expo 2024.April 2024GMG Provides Commercialisation Update on Energy Savings Coating THERMAL-XR® GMG Provides Commercialisation Update on Energy Savings Coating THERMAL-XR®December2024GMG Reaches Market Commercialisation Milestone on Energy Savings Coating THERMAL-XR® GMG Reaches Market Commercialisation Milestone on Energy Savings Coating THERMAL-XR®December2025USA EPA Approval Conditions Accepted for Graphene Coating THERMAL-XR® USA EPA Approval Conditions Accepted for Graphene Coating THERMAL-XR® About GMG:GMG is an Australian based clean-technology company which develops, makes and sells energy saving and energy storage solutions, enabled by graphene manufactured via in house production process. GMG uses its own proprietary production process to decompose natural gas (i.e. methane) into its natural elements, carbon (as graphene), hydrogen and some residual hydrocarbon gases. This process produces high quality, low cost, scalable, 'tuneable' and low/no contaminant graphene suitable for use in clean-technology and other applications.The Company's present focus is to de-risk and develop commercial scale-up capabilities, and secure market applications. In the energy savings segment, GMG has initially focused on graphene enhanced heating, ventilation and air conditioning ("HVAC-R") coating (or energy-saving coating) which is now being marketed into other applications including electronic heat sinks, industrial process plants and data centres. Another product GMG has developed is the graphene lubricant additive focused on saving liquid fuels initially for diesel engines.In the energy storage segment, GMG and the University of Queensland are working collaboratively with financial support from the Australian Government to progress R&D and commercialization of graphene aluminium-ion batteries ("G+AI Batteries"). GMG has also developed a graphene additive slurry that is aimed at improving the performance of lithium-ion batteries.GMG's 4 critical business objectives are:Produce Graphene and improve/scale cell production processesBuild Revenue from Energy Savings ProductsDevelop Next-Generation BatteryDevelop Supply Chain, Partners & Project Execution CapabilityFor further information, please contact:Craig Nicol, Chief Executive Officer & Managing Director of the Company at craig.nicol@graphenemg.com, +61 415 445 223Leo Karabelas at Focus Communications Investor Relations, leo@fcir.ca, +1 647 689 6041Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release.Cautionary Note Regarding Forward-Looking StatementsThis news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian and U.S. securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends", "believes" "expects" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or will "potentially" or "likely" occur. This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, GMG and Nu-Calgon's ability to leverage Nu-Calgon's distribution network to commence commercial sales of THERMAL-XR® ENHANCE-based products into the U.S. HVAC-R aftermarket, intentions as to the first shipment of THERMAL-XR® ENHANCE, the intended focus of initial THERMAL-XR® ENHANCE deployment, the energy efficiency, decarbonisation and corrosion protection benefits of THERMAL-XR® ENHANCE, GMG's intention to work with the EPA and GMG's intention to progress its broader THERMAL-XR® ENHANCE commercialisation activities.Such forward-looking statements are based on a number of assumptions of management, including the receipt of a fully signed consent notice from the EPA. Additionally, forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of GMG to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation that GMG does not receive or receive on a timely basis the fully signed consent notice from the and the risk factors set out under the heading "Risk Factors" in the Company's annual information form dated November 4, 2025 available for review on the Company's profile at www.sedarplus.ca.Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/288616 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Hello IP Reshapes Content Marketing Through a Creator-Driven Distribution Model
The Singapore-headquartered platform helps brands improve content reach and conversion in the era of short-form video and interest-based e-commerce. SINGAPORE – March 16, 2026 – (SeaPRwire) – As short-form video continues to reshape how information spreads and how consumers engage with brands, efficient collaboration between brands and creators has become increasingly important. Hello IP was built to address this need. Hello IP is a content distribution platform focused on social and interest-based e-commerce. By enabling brands to upload ready-made video content and distribute it through local creators across social platforms, Hello IP helps reduce the complexity of traditional creator collaborations, improve campaign efficiency, and create more sustainable monetization opportunities for creators. Under traditional creator marketing models, brands often face lengthy workflows that include influencer sourcing, repeated negotiation, contract signing, sample shipping, content review, and payment settlement. These processes can be slow, costly, and difficult to manage, especially in cross-border campaigns where shipping risks, inconsistent content quality, and uncertain outcomes remain common challenges. Hello IP offers a more efficient alternative. After brands upload content to the platform, creators can select tasks that match their style, audience, and interests, then distribute that content through their own channels. This model helps brands gain more localized and authentic exposure while allowing creators to earn performance-based rewards. To support faster market expansion, Hello IP has developed its core distribution system, Viral Engine, which combines creator distribution, influencer collaboration, advertising support, and cross-market strategies. The platform is currently active in mature TikTok e-commerce markets across Southeast Asia, the United Kingdom, and the United States, with content able to reach targeted creator communities in as little as 24 hours. For creators, Hello IP provides access to daily brand campaigns across categories such as beauty, mobile apps, e-commerce, and gaming. By lowering collaboration barriers and simplifying campaign participation, the platform helps creators unlock more stable income opportunities and build long-term commercial value. Mao Jianfeng, Founder of Hello IP, said, “In today’s creator economy, brands need content distribution models that are more efficient, scalable, and closely connected to local markets. Hello IP aims to build a smoother connection between brands and creators so that both sides can grow together.” As digital marketing enters a new phase, Hello IP’s connector model is creating a more efficient and inclusive path forward for the content ecosystem. About Hello IP Hello IP is one of ET CUBE’s core business pillars in the creator economy, focused on content distribution for social and interest-based e-commerce. Headquartered in Singapore, the platform connects brand content with local creator networks to help brands achieve faster, more authentic distribution and stronger conversion opportunities across key international markets. Media Contact Brand Name: Hello IP Website: https://www.helloipmcn.com
正大企业国际拟更名为正大生物 生物科技业务已成核心增长引擎 以创新和科研打造多元产品矩阵
EQS via SeaPRwire.com / 2026-03-16 / 19:20 UTC+8 正大企业国际拟更名为正大生物 生物科技业务已成核心增长引擎 以创新和科研打造多元产品矩阵 （2026年3月16日 – 香港）正大企业国际有限公司（股份代号：03839.HK）今日欣然宣布，拟更名为「正大生物控股有限公司」(CPBIO Holding Company Limited)（以下简称 「正大生物」或「本公司」）。此次更名计划旨在更精准体现本公司目前的主营业务及未来的战略布局，进一步强化本公司致力成为世界领先的生物科技公司的愿景。我们将以「正大生物」之名，继续携手全球伙伴，共推生物科技产业的可持续发展。有关建议更名事项尚待股东大会审议通过及百慕大公司注册处批准。 业务聚焦：生物科技贡献全部收入，继续成为核心增长引擎 此次更名计划是正大生物发展历程中的重要里程碑，精准反映本公司目前的收入全部来自 生物科技业务（动保兽药及金霉素产品）。未来，本公司将聚焦合成生物学、生物制品等前沿领域，以生物科技为核心驱动力，持续推动业务增长与行业可持续发展。 核心领域：以科研、创新及国际化为基础，把握全球畜牧业升级与生物安全趋势 正大生物立足于生命科学前沿，已实现向全球生物科技解决方案提供商的深度跨越。随着全球畜牧业向规模化、集约化与生物安全防控加速发展，市场对高效、安全的动保产品需求日益增长。我们将以此为契机，持续加强产品研发与技术创新，在不断拓展广阔国际市场的同时，与全球行业伙伴深化合作，以扎实的生物技术构建稳健的业务基础。 企业精神：践行愿景与使命，成为世界领先的生物科技公司 在以「正大生物」之名开启新篇章之际，我们更加坚定地传承并弘扬深植于心的企业精神。正大生物始终秉持“成为世界领先的生物科技公司”这一宏伟愿景，并以此引领各项业务的高质量发展。在这一愿景下，我们矢志不渝地履行企业使命 - 以创新的生物技术，健康动物，保护地球，造福人类。这份初心不仅是过去成功的基石，也将是未来驱动生物科技创新与应用的核心动力。 未来展望：前沿生物制品 及 合成生物技术 + AI赋能打造跨越周期的增长矩阵 正大生物将启动新的核心发展引擎：在夯实并升级核心生命健康底盘、深化全球资源协同与市场网络的基础上，公司将强力突破前沿创新生物制品的技术壁垒，并战略性规划高增长的宠物健康消费赛道；同时，我们将以尖端合成生物技术为产业链底层赋能，并全面构建AI与数据驱动的智慧化生态。新的发展引擎将互为协同，共同构筑具备强大穿越周期能力的多元化生物科技矩阵，为行业提供更系统、更深度的专业支撑，为股东、客户及合作伙伴创造长期、可持续的价值。 – 完 – 关于正大企业国际有限公司 正大企业国际有限公司（「正大企业国际」）（股份代号：03839.HK）2015年7月于香港联交所主板上市，业务包括生物科技业务及投资业务，并于中国的生物科技业界中建立强大的领导地位。 正大企业国际是卜蜂食品企业有限公司（大众）（股份代号：CPF.TB，简称「CPF」）的子公司。CPF是全球领先的农牧食品公司， 并于泰国证券交易所上市。 此新闻稿由金通策略有限公司代正大企业国际有限公司发布。 如有查询，请联络： DLK Advisory 金通策略 电话：+852 2857 7101 传真：+852 2857 7103 2026-03-16 此财经新闻稿由EQS via SeaPRwire.com转载。本公告内容由发行人全权负责。原文链接: http://www.todayir.com/sc/index.php
Hitachi Energy Japan Recognized as a 2026 Health & Productivity Management Outstanding Organization (Large Enterprise Category)
TOKYO, Mar 16, 2026 - (JCN Newswire via SeaPRwire.com) - Hitachi Energy Japan Ltd. has been recognized as a 2026 Health & Productivity Management Outstanding Organization (Large Enterprise Category) under the recognition program, jointly administered by Japan’s Ministry of Economy, Trade and Industry (METI) and Nippon Kenko Kaigi (Japan Health Council).Since 2023, the company has been recognized in the Small and Medium‑Sized Enterprise Category for three consecutive years. In 2026, Hitachi Energy in Japan was recognized for the first time in the Large Enterprise Category, reflecting its workforce growth. Organizations certified in this category are expected to lead by example, extending health and productivity management beyond their own operations to group companies, business partners, local communities, customers, and employees’ familiesPeople‑Centric HSE as a Foundation for the Energy TransitionAt Hitachi Energy, we promote “Health and Productivity Management”—activities designed to maintain and enhance employee health—guided by the Hitachi Group Safety and Health Policy, whose core principle is that safety and health always come first, and our global HSE*1 policy, which focuses on improving health and well‑being in the workplace.*1 Health, Safety, and Environment.With people at the heart of everything we do, Hitachi Energy views health and productivity management as a management foundation that underpins corporate value and social trust. By fostering a safe and healthy work environment through shared responsibility and continuous improvement, the company reinforces its role in advancing the energy transition and shaping a sustainable energy future for all.About the Health & Productivity Management Outstanding Organization Recognition ProgramThe Health & Productivity Management Outstanding Organization Recognition Program is a program established by Japan’s Ministry of Economy, Trade and Industry (METI) in fiscal year 2016. The program highlights large enterprises and small and medium‑sized enterprises that are implementing particularly excellent health and productivity management, and aims to develop an environment in which such organizations can gain enhanced recognition from employees, job seekers, related companies, and financial institutions. Marking its 10th year, the 2026 program recognized 3,765 organizations in the Large Enterprise Category and 23,085 organizations in the Small and Medium‑Sized Enterprise Category.ReferenceNippon Kenko Kaigi (Japan Health Council) – Official Website (Japanese)ACTION! Health & Productivity Management – Portal SiteAbout Hitachi EnergyHitachi Energy is a global technology leader in electrification, powering a sustainable energy future with innovative power grid technologies with digital at the core. Over three billion people depend on our technologies to power their daily lives. With over a century in pioneering mission-critical technologies like high-voltage, transformers, automation, and power electronics, we are addressing the most urgent energy challenge of our time – balancing soaring electricity demand, while decarbonizing the power system. With an unparalleled installed base in over 140 countries, we co-create and build long-term partnerships across the utility, industry, transportation, data centers, and infrastructure sectors. Headquartered in Switzerland, we employ over 50,000 people in 60 countries and generate revenues of around $16 billion USD.https://www.hitachienergy.comhttps://www.linkedin.com/company/hitachienergyhttps://x.com/HitachiEnergyAbout Hitachi, Ltd.Through its Social Innovation Business (SIB) that brings together IT, OT (Operational Technology) and products, Hitachi contributes to a harmonized society where the environment, wellbeing, and economic growth are in balance. Hitachi operates globally in four sectors – Digital Systems & Services, Energy, Mobility, and Connective Industries – and the Strategic SIB Business Unit for new growth businesses. With Lumada at its core, Hitachi generates value from integrating data, technology and domain knowledge to solve customer and social challenges. Revenues for FY2024 (ended March 31, 2025) totaled 9,783.3 billion yen, with 618 consolidated subsidiaries and approximately 280,000 employees worldwide. Visit us at www.hitachi.com Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
Bonus Savings Account: What It Is and How It Helps You Earn More Interest
SINGAPORE, Mar 16, 2026 - (ACN Newswire via SeaPRwire.com) - In a world where living costs continue to rise, making your money work harder for you is a necessity. While a standard savings account offers a base interest rate, a bonus savings account allows you to earn higher interest by meeting specific conditions.By understanding the mechanics of these accounts, you can turn your idle cash into a productive asset. This article explores the features of these accounts and how they can help you reach your financial goals sooner.What is a Bonus Savings Account?A bonus savings account is a type of bank account that rewards you with higher interest rates when you meet specific conditions. Unlike a basic account that pays a flat, low rate regardless of your activity, these accounts are designed to encourage healthy financial habits.Generally, your total interest is split into two parts: base interest and bonus interest. The base interest is what you earn on every dollar, regardless of your activity. The bonus interest is an additional percentage added when you fulfil certain requirements, such as increasing your monthly balance or spending on a linked credit card.How a Bonus Savings Account Helps You Earn MoreThe primary appeal of a bonus savings account is the ability to earn interest rates that are often several times higher than standard savings accounts. Here is how they help you maximise your earnings:1. Rewarding Consistent Savers: Many accounts reward you for not spending your money. For example, some accounts offer bonus interest if your monthly average balance increases compared to the previous month. This encourages you to keep your funds in the account rather than withdrawing them for impulsive purchases, allowing compounding to work in your favour.2. Consolidating Your Financial Activities: Banks often use a bonus savings account to reward loyalty. You might earn extra interest by linking your salary credit or meeting a minimum spend on the bank's credit cards. By centring your financial activities around one account, you can unlock higher tiers of interest than with a basic savings plan.3. Tiered Interest Structures: Most bonus accounts use a tiered system. This means that as your balance grows, the interest rate on specific brackets of your funds increases. This structure is particularly beneficial for those with growing savings, as it allows larger balances to earn higher rates.Common Requirements to Unlock Bonus InterestTo make the most of a bonus savings account, you need to understand the typical requirements. Banks in Singapore usually look for the following:Balance Growth: Maintaining or increasing your balance month on month.Salary Credit: Having your monthly take-home pay credited directly into the account via your employer.Spend Requirements: Using a linked debit or credit card for a minimum amount (often SGD 500) each month.Investing or Insuring: Purchasing eligible insurance or investment products through the bank.Is a Bonus Savings Account Right for You?While the high interest rates are attractive, a bonus savings account is most effective when it aligns with your natural spending and saving habits.If you are someone who saves a portion of your income every month and rarely withdraws from your reserves, an account that rewards balance growth is an excellent fit. However, if you prefer an account that doesn't require you to track credit card spending or investment tiers, you may want to consider a simpler savings account.Strategies to Maximise Your InterestTo ensure you never miss out on your bonus interest, consider these simple steps:Automate Your Savings: Set up a standing instruction to move a fixed amount into your bonus savings account every month. This ensures your balance grows consistently without you having to remember to do it manually.Track Your Monthly Average Balance: Be mindful of the mid-month balance rather than just the balance on the last day of the month. Large withdrawals in the middle of the month may lower your average balance.Consolidate Spending: If your account requires a minimum card spend, try to put all your essential costs, such as groceries, transport, and utilities, on that specific card to hit the target easily.Final ThoughtsA bonus savings account can be a useful tool for improving returns on your cash savings. It transforms the act of saving from a passive habit into a rewarding strategy. By choosing an account that fits your lifestyle and staying disciplined with the requirements, you can help your hard-earned money grow at a higher rate.Disclaimer: This article is for general information only and does not have any regard to the specific investment objectives, financial situation and particular needs of any specific person. The views expressed in this article are solely those of the author. This article shall not be regarded as an offer, recommendation, solicitation or advice. You may wish to consult your own professional advisers about this article, in particular, a financial professional before making financial decisions. Any past events, trends and/or performance referred to in this article may not necessarily be indicative of future events, trends or performance. This article is based on certain assumptions and reflects prevailing conditions as at the time of publication, which are subject to change at any time without notice. The author and publisher of this article as well as any other parties associated with this article make no representation or warranty of any kind, whether express, implied or statutory, in respect of this article and accept no liability or responsibility for the completeness or accuracy of this article or any error, inaccuracy or omission relating to this article and/or any consequence, injury, loss or damage howsoever suffered by any person relating to this article, in particular, arising from any reliance by any person on this article. Publishers or platforms may be compensated for access to third party websites.Contact Information:Name : Sonakshi MurzeEmail : Sonakshi.murze@iquanti.comJob Title : ManagerSOURCE: iQuanti Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
CMS (867.HK/8A8.SG) : New Drug for Renal Anaemia Desidustat Tablets Approved in China
SHENZHEN, CHINA, Mar 13, 2026 – (ACN Newswire via SeaPRwire.com) – China Medical System Holdings Limited (“CMS”, or the “Group”) is pleased to announce that on 13 March 2026, new drug for renal anaemia Desidustat Tablets (the “Product”) has been approved for marketing in China by the National Medical Products Administration of the People’s Republic of China (NMPA). The Product is a novel, oral HypoxiaInducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI) for treating anaemia in non-dialysis adult, Chronic Kidney Disease (CKD) patients. The approval of Desidustat Tablets will further strengthen the Group’s overall layout in the field of nephrology, and synergize with the marketed innovative drug Velphoro (Sucroferric Oxyhydroxide Chewable Tablets, indicated for CKD hyperphosphatemia). Through the efficient linkage of nephrology expert resources and channel networks, the Group is expected to rapidly promote the large-scale clinical application of Desidustat Tablets, providing differentiated treatment options for Chinese CKD patients with renal anaemia and making a positive contribution to the Group’s performance. More information about Desidustat Tablets and Renal Anaemia As a novel oral HIF-PHI, the Product’s mechanism of action promotes erythropoiesis through increasing endogenous erythropoietin, improving iron availability and reducing hepcidin. Its China Phase III clinical trial has demonstrated positive results. The primary endpoint of the haemoglobin (Hb) mean change from baseline to Week 7-9 has indicated that, Desidustat is more effective than placebo in increasing Hb level. Results from the extension study demonstrate that the Product can maintain Hb level within the target range over the long term with acceptable safety. In addition, the Product significantly reduces hepcidin levels and ameliorates iron metabolism disorders. There is still a large unmet need in the treatment of anaemia in CKD patients in China. It is estimated that there are more than 120 million CKD patients in China[1]. Anaemia is one of the frequent complications of CKD, which exhibits a progressively increasing incidence with disease progression. A survey in China showed that the prevalences of anaemia in patients at CKD stage 1 to 5 were 22.0%, 37.0%, 45.4%, 85.1%, and 98.2%, respectively[2]. The target-achieving rate (the Hb level reaching the target value (110~120g / L)) has increased to 51.5% for haemodialysis CKD patients with anaemia[3], but is still only 8.2% for anaemia patients in non-dialysis CKD[4]. The Product is administrated orally, thus expecting to improve the treatment compliance of patients and to meet the unmet treatment needs in the field of CKD anaemia. Desidustat Tablets have been approved for marketing in India. CMS INTERNATIONAL DEVELOPMENT AND MANAGEMENT LIMITED, a wholly-owned subsidiary of the Group, obtained an exclusive license for the Product from Zydus Lifesciences Limited (earlier known as Cadila Healthcare Limited) pursuant to a License Agreement with an effective date of 20 January 2020. The Group adheres to its core strategy of “innovation-driven”, having established a tiered and multi-dimensional innovation product portfolio with abundant reserves: 7 new drugs have been approved for marketing, 6 are currently under marketing review, and nearly 20 projects are about to initiate or are progressing through clinical trials. Through a dual-engine innovation approach combining collaborative development and in-house R&D, the Group continuously enriches its innovative pipeline centered on first-in-class (FIC) and best-in-class (BIC) products, efficiently advancing clinical development and commercialization. Moving forward, CMS will remain clinical needs-driven to deliver more quality pharmaceutical solutions, steadfastly advancing toward the goal of becoming a specialty-focused, innovation-excellent multinational pharmaceutical enterprise. About CMS CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs. CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients. CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the Cardiovascular-Kidney-Metabolic/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group. Reference 1. ZhangL, WangF, WangL, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet, 2012, 379(9818):815-822. DOI: 10.1016/S0140-6736(12)60033-6 2. Chinese Expert Consensus on the Diagnosis and Treatment of Renal Anemia (2014 Revised Edition)[J]. Chinese Journal of Nephrology, 2014, 30(9): 712-716. DOI: 10.3760/cma.j.issn.1001-7097.2014.09.015 3. 19th CSN Critical Care & Blood Purification Congress, Chinese Medical Association (July 2-5, 2025) 4. Chinese Expert Consensus on the Diagnosis and Treatment of Renal Anemia (2018 Revised Edition)[J]. Chinese Journal of Nephrology, 2018, 34(11): 860-866. DOI: 10.3760/cma.j.issn.1001-7097.2018.11.012 CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections. Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsWebsite: https://web.cms.net.cn/en/home/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
China Lilang Announces 2025 Annual Results
HONG KONG, Mar 16, 2026 - (ACN Newswire via SeaPRwire.com) – China Lilang Limited (“China Lilang” or the “Company”, together with its subsidiaries, the “Group”; stock code: 1234) today announced its results for the year 2025.Mr. Wang Dong Xing, Chairman and Non-Executive Director of China Lilang, said: “In 2025, against a backdrop of steady macroeconomic recovery and moderate growth in the consumer market, the apparel industry in the Chinese Mainland maintained an overall stable development trajectory despite facing pressure. Amid the broader trend of consumption upgrading, the menswear market is undergoing structural differentiation, with mid-to-high-end segments such as business casual and smart casual becoming core growth drivers. The industry is accelerating its transition from 'quantity-driven competition' towards a stage of high-quality competition centered on 'innovation, quality and sustainable development. China Lilang deepened its presence in the menswear market with its differentiated brand matrix, building a diversified business portfolio through the 'LILANZ' core collection, the 'LESS IS MORE' smart casual collection and the 'MUNSINGWEAR' sports line, to comprehensively meet market demand for high-quality, diverse apparel. At the same time, the Group optimized its omni-channel marketing layout, strengthened online-offline operational synergies, actively expanded into emerging online platforms while accelerating the DTC model offline, and simultaneously advanced its internationalization strategy to enhance brand influence and operational efficiency across multiple dimensions.”During the year, the Group's revenue increased by 11.5% year-on-year to RMB4.07 billion. Revenue from the smart casual and other collections surged by 28.4%, primarily driven by a significant increase in average sales per store and the outstanding performance of new retail channels. Revenue from the core collection grew by 6.0%, mainly due to the initial operational efficiencies generated during the year following the Group's transition to a DTC model after reclaiming distribution rights from distributors starting last year.Gross profit margin increased by 1.9 percentage points year-on-year to 49.6%, mainly due to the increase in average unit price as a result of a higher proportion of direct-to-retail sales, coupled with a smaller one-off deduction from revenue arising from the recovery of distribution rights. Profit attributable to equity shareholders was RMB502 million (2024: RMB460 million), representing an increase of 9.0%. The profit margin attributable to equity shareholders decreased by 0.3 percentage points year-on-year to 12.6%. Earnings per share increased by 9.0% to RMB41.96 cents.The Board has recommended a final dividend of HK13 cents per share (2024: HK9 cents) and a special final dividend of HK3 cents per share (2024: HK3 cents). Together with the interim dividend already paid, the total dividend for the year amounted to HK32 cents per share, maintaining a stable dividend payout ratio.During the year, the Group adhered to its core strategy of ensuring a well-differentiated brand matrix and deepening its presence in the menswear market. The "LILANZ" core collection continued to consolidate its competitive advantage in the traditional menswear market. By optimizing product structure and deepening regional channel deployment and penetration, it further enhanced brand awareness and market share in key markets. Having successfully completed the repurchase and transformation of distribution rights in Northeast China and Jiangsu Province last year, the Group accelerated channel innovation throughout the year, subsequently acquiring the operating rights of first-tier distributors in Shandong Province and Chongqing City. The "LESS IS MORE" smart casual collection, targeting younger consumers, continued to operate under a fully direct-to-retail model, with its store opening strategy focused on shopping malls, which is preferred by consumers to enhance the consumer experience through a precisely tailored store image. As at the end of December 2025, there were 2,446 stores for the core collection and 371 stores for the smart casual and other collections, a total of 2,817 stores with a net increase of 44 stores.During the year, the Group continued to focus on opening stores in prime locations within premium shopping malls and outlet centers, attracting customers and boosting sales through distinctive brand-specific renovations. As at 31 December 2025, the number of stores located in shopping malls and outlet stores increased to 1,135 (31 December 2024: 1,036).The Group completed strategic transformation of its new retail business, upgrading it from an inventory clearance channel into a major new product sales platform. Revenue from this segment recorded a significant increase of 25% during the year. While continuing to strengthen its presence on mature sales platforms like Tmall, JD.com and TikTok, the Group has also expanded into emerging channels such as Pinduoduo, Wechat Channels and Poizon, creating a diversified online sales network altogether. The Group made full use of social platforms such as Xiaohongshu and Weibo to continuously produce high-quality content to strengthen its content-driven e-commerce strategy. This approach not only deepened the emotional connection with consumers but also effectively expanded the young customer base, opening new growth opportunities for the new retail business.Regarding the "Multi-brands and Internationalization" development strategy, the premium golf apparel brand "MUNSINGWEAR", a key element of the Group's multi-brand strategy, successfully completed its transaction closing in the first half of the year. In the second half, it opened its first batch of physical stores in locations including Chongqing and Jinjiang, further enriching the Group's diversified brand portfolio and premium product lines. Meanwhile, the Group's plan to open its first store in Malaysia was successfully implemented and the first stores commissioned in May. In November, it opened the world's first "Future Retail" concept flagship store at Pavilion Bukit Jalil, a core business district in Kuala Lumpur. By the end of December 2025, 4 stores had been opened. The smooth operation of all stores not only completed the initial layout in the Southeast Asian market but also laid an important foundation for the Group’s subsequent expansion across the region.During the year, the Group adhered to its core design philosophy of "Simplicity but Not Simple", deepening proprietary research and development across its industrial chain. It implemented a core premium product strategy, focusing on fabric innovation, craftsmanship upgrades and standard-setting to strengthen its competitive advantage of "Technology-Empowered Products", while transforming its technological expertise into industry-wide reference standards.Facing a market environment where opportunities and challenges coexist, China Lilang will maintain a prudent yet optimistic stance and continue to pursue its core strategy of "Multi-brands and Internationalization". It will advance channel reforms, strengthen product innovation and enhance operational efficiency, to bolster its leading position in China's menswear industry. The Group plans for a net increase of approximately 50 to 100 stores in 2026, with the focus remaining on premium shopping malls and outlets. At the same time, the Group will further consolidate the operating results of the regions that have transitioned and explore the possibility of rolling out the DTC model in other suitable regions to deepen market control and elevate consumer experience.In the new retail business, the Group will continue to advance its online channel layout, aiming to achieve over 15% growth in new retail sales in 2026. Through content-focused e-commerce and targeted live streaming, the Group seeks to reach more young customers and drive overall sales growth of 10%.The Group will steadily advance the business development of "MUNSINGWEAR", planning to continue expanding its physical store network in the Chinese Mainland and expanding its online sales channels to achieve online-offline synergy. In terms of international expansion, following its successful entry into the Malaysian market, the Group's company registration process in the Philippines has been completed, with business operations expected to officially commence in 2026, gradually refining its overseas channel layout.Mr. Wang Dong Xing, Chairman of China Lilang, concluded: “Looking ahead to 2026, the global geopolitical landscape remains complex and volatile, but the Chinese government continues to introduce policies and measures to promote consumption and expand domestic demand, providing support for the domestic market. Building upon the solid foundation established in 2025, China Lilang will focus on the development of its 'LILANZ' core collection and 'LESS IS MORE' smart casual collection, while deepening its new retail strategy and advancing multi-brand and overseas businesses, enabling it to advance towards a new stage of growth characterized by improvements in both quality and efficiency. It will also continue to drive R&D innovation and strength its ESG initiatives, achieving concurrent business growth and sustainable development, striving to create stable and sustainable returns for shareholders."About China LilangChina Lilang is one of the leading PRC menswear enterprises. As an integrated fashion enterprise, the Group designs, sources and manufactures high-quality business and casual apparel for men and sells under brands of 'LILANZ' and 'LESS IS MORE' across an extensive distribution network, mainly in the PRC and overseas. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
中国利郎公布二零二五年全年业绩
香港, 2026年3月16日 - (亚太商讯 via SeaPRwire.com) - 中国利郎有限公司（"中国利郎"或"公司"，及其附属公司，统称"集团"；股份编号：1234）今天公布其二零二五年全年业绩。中国利郎主席兼非执行董事王冬星先生说："二零二五年，中国内地服装行业在宏观经济稳步复苏与消费市场温和增长的背景下，整体保持基本稳定、承压前行的发展态势。男装市场在消费升级大趋势下呈现结构性分化，商务休闲、轻商务等中高端细分赛道成为增长核心动力，行业正加速从'数量竞争'迈向以'创新、品质与可持续发展'为核心的高质量竞争阶段。中国利郎以差异化品牌矩阵深耕男装市场，通过'利郎 LILANZ'主系列、'利郎 LESS IS MORE'轻商务系列及'万星威 MUNSINGWEAR'运动线构建多元业务布局，全方位满足市场高品质、多元化的消费需求。同时，集团优化全渠道营销布局，强化线上线下协同营运，线上积极拓展新兴平台、线下加速推动DTC模式，同步推进国际化布局，多维度提升品牌影响力与营运效能。"年内，集团收入同比增长11.5%至人民币40.7亿元。其中，轻商务及其他系列收入大幅上升28.4%，主要得益于单店平均销售额的大幅提升以及新零售渠道的突出表现。主系列收入增长6.0%，主要由于集团自去年起从分销商收回分销权转以DTC模式经营后，于年内初步产生经营效益。毛利率为49.6%，同比上升1.9个百分点，主要因为直营销售占比上升提高平均单价，加上因收回分销权产生的一次性收入扣除有所减少所致。权益股东应占利润为人民币5.0亿元（二零二四年：人民币4.6亿元），同比上升9.0%。股东应占利润率为12.3%，同比下降0.3个百分点。每股盈利同比上升9.0%至人民币41.96分。董事会建议派发末期股息每股13港仙（二零二四年：9港仙）及特别末期股息每股3港仙（二零二四年：3港仙），连同已派发的中期股息，全年每股派息合共32港仙，维持稳定的派息比率。集团于年内以差异化品牌矩阵为核心战略，深耕男装市场。"利郎 LILANZ"主系列持续巩固传统男装市场的竞争壁垒，透过优化产品结构、深化区域渠道布局与渗透，进一步提升品牌在核心市场的认知度与市场份额。继去年完成东北地区及江苏省的分销权回购转制后，集团于年内加速推进渠道革新，再完成收回山东省及重庆市一级分销商的经营权。针对年轻消费者的"利郎 LESS IS MORE"轻商务系列继续以全直营模式经营，开店策略集中在消费者偏好的购物中心，以精准的门店形象提升消费体验。截至二零二五年十二月底，主系列门店共2,446家，轻商务及其他系列门店371家，整体共2,817家门店，净增加44家。年内，集团继续集中在优质购物中心中的优越铺位和奥特莱斯开店，通过最具品牌个性的装修吸引顾客，提升销售。于二零二五年十二月三十一日，购物中心店及奥特莱斯店增加至1,135家（二零二四年十二月三十一日：1,036家）。集团新零售业务完成战略转型，从过往的库存清理渠道升级为主力新品销售平台，年内收入录得25%的显著增长。集团持续深耕天猫、京东、抖音等成熟销售平台的同时，拓展了拼多多、微信视频号、得物等新兴渠道，形成多元化线上销售网络。集团同时利用小红书、微博等社交平台，持续输出高品质内容，强化内容电商布局，不仅深化了与消费者的情感联结，更有效拓展了年轻客群，为新零售业务打开新的增长空间。「多品牌、国际化」发展战略方面，高端高尔夫服饰品牌"万星威 MUNSINGWEAR"作为集团多品牌战略的关键布局，上半年完成交易交割后，下半年在重庆及晋江等地开设首批实体门店，进一步丰富了集团的多元化品牌组合与高端产品线。而集团在马来西亚开设首家门店的计划顺利落实，并于五月份顺利试业。十一月于吉隆坡核心商圈Pavilion Bukit Jalil开设全球首家"未来商业（Future Retail）"概念旗舰店。于二零二五年十二月底已经开设4家门店，所有门店的顺利营运，不仅完成了东南亚市场的初步布局，更为集团后续辐射东南亚市场奠下重要基础。年内，集团贯彻"简约不简单"的设计核心，深化全产业链自主研发，打造核心精品单品战略，专注面料创新、工艺升级与标准制定，加强"技术赋能产品"的竞争优势的同时更将自身技术积累转化为全行业可参照的规范标准。面对机遇与挑战并存的市场环境，中国利郎将保持审慎乐观的态度，继续深耕"多品牌、国际化"核心战略，推进渠道改革、强化产品创新、提升运营效率，巩固并提升集团于中国男装行业的领先地位。集团计划于二零二六年全年净增加约50至100家门店，开店重点继续聚焦于优质购物中心及奥特莱斯。同时，集团将进一步巩固已转型区域的经营成果，并探索在更多合适区域推广DTC模式，以强化市场控制力、提升消费体验。新零售业务方面，集团将持续推进线上渠道布局，目标二零二六年实现新零售销售额增长15%以上，并通过内容电商与精准直播触达更多年轻客群，带动整体销售实现10%增长。集团将稳步推进"万星威 MUNSINGWEAR"的业务发展，计划在中国内地继续拓展实体门店网络，并拓展线上销售渠道，实现线上线下联动。国际化拓展方面，继马来西亚市场后，集团在菲律宾的公司注册程序已完成，预计于二零二六年内正式开展业务，逐步完善海外渠道布局。王冬星主席总结说："展望二零二六年，全球地缘政治格局依然复杂多变，但中国政府持续推出促进消费、扩大内需的政策措施，为国内市场提供支撑。中国利郎将立足于二零二五年所奠定的稳健基础，在聚焦'利郎 LILANZ'主系列及'利郎LESS IS MORE'轻商务发展的同时，深化新零售战略，推进多品牌及海外业务，从而向质量与效率双升的高阶增长阶段迈进，并将继续透过研发创新，持续加强 ESG 建设，实现业务增长与可持续发展并行，致力为股东创造稳健及可持续的回报。"关于中国利郎中国利郎是中国领先的男装企业之一。作为一家综合时装企业，集团设计、采购、生产并以品牌"利郎LILANZ"及"利郎LESS IS MORE"销售优质男士商务及休闲服装。其产品主要于中国及海外的广阔零售及分销网络销售。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Fujitsu Japan and Teikyo University Hospital launch joint proof of concept to build mechanism for data analysis and referred-patient management
Kawasaki and Tokyo, Japan, Mar 16, 2026 - (JCN Newswire via SeaPRwire.com) - Fujitsu Japan Limited and Teikyo University Hospital today announced the start of a joint proof of concept aimed at strengthening regional medical collaboration. The initiative, which commenced on March 16, focuses on developing new information analysis and patient management mechanisms utilizing medical administration systems and electronic health record data. This will facilitate the prompt admittance of severely ill patients requiring hospitalization or surgery and a smooth transition back to primary care after discharge.This joint experiment will implement the following initiatives for Teikyo University Hospital's regional medical collaboration operations:1. Digitalization of Patient Workflow from Referral Acceptance to Discharge CoordinationBy introducing AI-OCR and electronic paper for referral reception and discharge coordination, information from outside the hospital will be digitized. This will be seamlessly integrated with electronic health records and regional medical collaboration information systems, aiming to eliminate duplicate data entry and improve overall operational efficiency.2. Verification of the Health Care Management Platform for Data-Driven Strategic Patient AcquisitionBased on data from medical accounting systems and electronic health records, Health Care Management Platform, an offering under Fujitsu Limited's Uvance business model which addresses societal challenges, will be used to visualize and analyze trends in referred patients and collaborating facilities in a timely manner. This will enable the identification of facilities where collaboration should be strengthened, and actual visits to these facilities will be conducted to enhance regional collaboration. Visit records and results will be registered and accumulated in Salesforce's Agentforce 360 Platform, aiming to utilize this information for analyzing referral performance and formulating strategies that comprehensively address the needs of collaborating facilities.Figure: Patient workflow in regional medical collaboration and a joint proof of conceptThrough this initiative, Teikyo University Hospital aims to reduce the administrative workload of its Medical Collaboration Office, which handles regional collaboration tasks, by 30%, while contributing to the provision of high-quality and prompt medical care and the optimization of medical resources for patients.Moving forward, both parties will expand the scope of integration between this system and electronic health records to centrally manage the patient workflow, including treatment processes after referral acceptance. This will contribute to providing medical care to patients at more appropriate times and supporting decision-making for healthcare professionals, thereby improving hospital management and fostering regional medical collaboration.Fujitsu Japan will leverage the insights from this joint experiment to enhance accuracy and add new functionalities to its offerings, supporting Teikyo University Hospital's digital transformation (DX) and the promotion of digital hospitals. Furthermore, under Uvance, Fujitsu Japan will drive the transformation of medical practice workflows through data and AI, advancing the establishment of a sustainable healthcare delivery system.Teikyo University Hospital will systematize this mechanism as a model for realizing a data-driven regional healthcare system and promote its expansion to other medical institutions and regions. Through this initiative, the hospital also aims to further enhance the role and value of its Medical Collaboration Office, which serves as the hospital's public face, and build a foundation for the office to function as a hub for regional medical care, moving beyond its traditional role of handling referral reception and coordination.BackgroundJapanese healthcare faces a challenging management environment due to a declining birthrate, an aging population, and rising material costs, while medical needs are becoming increasingly complex due to advancements in medical technology. To ensure sustainable healthcare, it is essential to strengthen collaboration between primary care physicians and specialists, ensuring patients are referred at appropriate times, receive advanced treatment, and are then referred back to their primary care physicians for ongoing care. This kind of regional medical collaboration is essential.The Japanese government is also promoting medical DX and functional differentiation and collaboration within regions, establishing evaluations and incentives in the fiscal year 2026 medical fee revision.As a specialized hospital in the Itabashi Ward region, Teikyo University Hospital accepts over 30,000 referred patients annually and has actively promoted regional collaboration through continuous lectures and visits to medical institutions. Regarding referred patient acceptance, the hospital receives approximately 200 calls daily from patients and medical institutions, utilizing up to eight lines at a time. A key challenge has been the time and burden placed on reception staff to coordinate referred patient acceptance, especially for urgent referrals and transfer requests from other medical institutions, often requiring consultation with doctors, leading to waiting times for outpatient appointments and hospitalization.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers around the globe, our 113,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: AI, Computing, Networks, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$23 billion) for the fiscal year ended March 31, 2025 and remains the top digital services company in Japan by market share. Find out more: global.fujitsuPress ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
Accelerated Technology Commercialization Drives High-Growth Performance, Qunabox Group Leads the AI Interactive Marketing Track
HONG KONG, Mar 16, 2026 - (ACN Newswire via SeaPRwire.com) – As the integration of artificial intelligence technology with physical consumption scenarios enters a deeper stage, a dual revolution in business efficiency and consumer experience is unfolding. As a leader in China’s AI interactive marketing services sector, Qunabox Group (00917.HK) has achieved both rapid performance growth and a turnaround to profitability by leveraging its innovative business model of "technology middleware platform + multi-business synergy + global scenario deployment", setting a new benchmark for the digital transformation of the industry.AI-Powered Marketing Services, Building a Dual-Engine Model of "Technology + Data"At the core of Qunabox Group’s business model is the creation of a technology-driven, end-to-end value closed loop that upgrades AI from a single functional tool to a core engine embedded throughout the entire consumer journey. Marketing services, as the Group’s core business segment, has developed a dual-engine model of "standardization + value-added services", which continuously optimizes revenue quality and gross profit structure.In terms of service model, the Group has deeply covered key consumer sectors such as food and beverages, daily necessities, new energy vehicles and household appliances. With a high-quality, stable and diversified brand customer base as its foundation, the Group keeps deepening cooperation with major clients by expanding service scenarios and optimizing product portfolio, thus achieving simultaneous growth in both the number of clients and the value generated per client.In terms of product innovation, the Group takes technological R&D as the key driver, enabling AI to act as the "execution agent" throughout the end-to-end marketing value chain. The upgraded AI digital human shopping assistant, equipped with cross-sensory intent recognition and high-precision 3D modeling, delivers precise personalized recommendations and elevates user experience. The newly launched AI holographic marketing cabinet creates immersive display scenarios for high-intelligence products, restructuring the interaction mode of offline marketing. Meanwhile, the AI Agent marketing workstation enables closed-loop management across the entire process from content planning to performance tracking, raising marketing execution efficiency and precision to a new level.In the meantime, the implementation of the AIGC marketing resource library and the marketing selling points database for beverages and snack foods has made data value the core support for marketing decision-making, forming a new marketing service model driven by the dual wheels of "technology + data" and further consolidating the Group’s leading position in the field of AI interactive marketing.Global Layout in Innovative Tracks, R&D Innovation to Build Solid BarriersLifestyle and innovative businesses have injected long-term growth momentum into the Group’s business model. Focusing on "AI + Lifestyle", the Group has proactively explored emerging markets, with key focus on the Middle East, Southeast Asia and Australia where the demand for high-quality technology-enabled experiential consumption is robust. An overseas business department has been established to achieve end-to-end localized operation and management. At present, the AI indoor entertainment space has completed preliminary preparation and successfully obtained relevant business licenses in Dubai and Singapore.From the validation of localized models to the integration of software and hardware systems, and from the building of professional teams to the development of content ecosystem, the Group has realized cross-cultural and multilingual adaptation of its AI technologies through refined operation and management. This has allowed its "AI + consumption scenarios" business model to expand beyond domestic markets, providing innovative solutions for the upgrading of global consumer markets.In addition, other service businesses including IT system development leverage the Group’s technological reserves and first-mover advantages in AI applications to undertake technology development demands from industrial clients. These businesses have become an important extension of the commercialization of the Group’s technological capabilities, further enriching the Group’s revenue structure.In building technological barriers, Qunabox Group deeply integrates R&D innovation with intellectual property protection. The number of software copyrights registered in China and patents held by the Group has increased to 173 and 22 respectively, with an additional 133 patents currently under application, making technological innovation a solid guarantee for the sustainable development of the Group’s business model.At present, the integration of artificial intelligence and physical consumption is entering a phase of accelerated large-scale implementation. With its business model centered on "AI + Consumption Scenarios", Qunabox Group has not only achieved high-quality development for itself, but also reshaped the value creation model of the consumer industry.Looking ahead, Qunabox Group will continue to deepen its technological advantages and service capabilities, advance strategic industrial mergers and acquisitions, and optimize its AI-powered experiential consumption business model. By leveraging the synergy of new technologies, new scenarios and new markets, the Group aims to build a cross-regional, end-to-end AI lifestyle platform. It will keep driving industry innovation and progress, creating commercial value for brand clients, delivering new experiences for consumers, and generating long-term value for shareholders and society. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
FWD Group delivers record full year 2025 results with profitable growth, improved capital and cash flow generation
HONG KONG, Mar 16, 2026 - (ACN Newswire via SeaPRwire.com) – FWD Group Holdings Limited (“FWD Group” or “FWD”) today announced its first set of full-year results as a Hong Kong listed company for the 12 months ended 31 December 2025.- New business sales were up 25 per cent to US$2.446 billion compared to 2024 on an annualised premium equivalent (APE) basis. New business contractual service margin (CSM) was US$1.476 billion, with year-on-year growth of 18 per cent.- Operating profit after tax was up five per cent to US$499 million with positive contributions from each of the company’s four geographic reporting segments – Hong Kong SAR & Macau SAR; Thailand & Cambodia; Japan; and Emerging Markets.- Net profit of US$166 million is a record IFRS 17 result and for the second consecutive year, FWD Group was operating cash flow positive as at 31 December 2025. Leverage ratio reduced to 21.3 per cent approaching the company’s target range of 15-20 per cent.- Significantly increased important indicators of shareholder value creation, with comprehensive tangible equity (CTE) up 18 per cent to US$8.72 billion compared to 31 December 2024 and Group embedded value (EV) up 19 per cent year-on-year to US$6.85 billion. A strong capital position was maintained with a 265 per cent solvency ratio^.- In December 2025, FWD Group was added to the Hang Seng Composite Index and the eligible securities list for the Stock Connect programme, where Mainland Chinese investors connect via the Shanghai Stock Exchange and Shenzhen Stock Exchange with Hong Kong market opportunities via a southbound trading mechanism. FWD Group was also included in the MSCI Hong Kong Small Cap Index in February 2026.Huynh Thanh Phong, Group Chief Executive Officer and Executive Director of FWD Group, said, “2025 was a stand-out year for FWD Group. We successfully executed our customer-led strategy, underpinned by our digitally enabled business model. Record financial results were achieved. And of course, we began trading as a publicly listed company, following our July 2025 initial public offering. This fulfilled a long-held objective to ensure FWD Group has full capital market access, as a solid foundation for our future development and growth.”The strong 2025 results were driven by organic growth across most of the 10 Asian markets where FWD Group operates, with a particularly outstanding performance in the Hong Kong SAR & Macau SAR segment.A solid performance was posted in Japan, in a year where FWD began to diversify beyond its successful protection business into the retirement and savings segment, with its first offering – a yen-denominated single premium variable annuity product.As an established market leader in Thailand, FWD remains well positioned to grow quality new business in future, despite headwinds from a lower rate environment which impacted 2025 results, in addition to the 2024 exit from underwriting new business in the corporate care segment.Excellent growth was delivered in the Emerging Markets segment – which is comprised of five of the rest of FWD Group’s Southeast Asian markets – consistent with the longer-term demographic, wealth creation, and digital adoption trends in this region.“With 2026 already underway, we remain firmly focused on executing our strategy as we build for the future – operating with customers at the heart of everything we do in high-growth Asian markets, with a focus on long-term sustainability and profitability,” added Huynh Thanh Phong.About FWD GroupFWD Group (1828.HK) is a pan-Asian life and health insurance business that serves more than 38 million customers across 10 markets, including BRI Life in Indonesia. FWD’s customer-led and tech-enabled approach aims to deliver innovative propositions, easy-to-understand products and a simpler insurance experience. Established in 2013, the company operates in some of the fastest-growing insurance markets in the world with a vision of changing the way people feel about insurance. FWD Group is listed on the main board of the Hong Kong Stock Exchange under the stock code 1828.For more information, please visit www.fwd.comFor media inquiries, please contact: groupcommunications@fwd.comSource: FWD Group Holdings LimitedThe results are for the 12 months ended 31 December 2025 and are compared to the same period in 2024.Group LCSM cover ratio, group embedded value, comprehensive tangible equity values are December 2025 balances/ratios and growth rates are represented accordingly.Growth rates are represented on a constant exchange rate (CER) basis, unless otherwise stated.Except for operating profit/(loss) after tax (non-IFRS measure), net profit/(loss), and comprehensive tangible equity, all other numbers are unaudited. Operating profit after tax and net profit after tax represent the amounts attributable to equity holders of the company and are presented net of non-controlling interests. New business sales are calculated on an annualised premium equivalent (APE) basis, based on 100 percent annualised first year premiums and 10 percent single premiums. Comprehensive tangible equity is calculated as total equity of the Group attributable to shareholders of the Company plus contractual service margin (net of tax and non-controlling interests), minus intangible assets (net of non-controlling interests).* Actual exchange rate basis ^ Prescribed capital requirement (PCR) basis Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
FWD Group delivers record full year 2025 results with profitable growth, improved capital and cash flow generation
HONG KONG, Mar 16, 2026 - (ACN Newswire via SeaPRwire.com) – FWD Group Holdings Limited (“FWD Group” or “FWD”) today announced its first set of full-year results as a Hong Kong listed company for the 12 months ended 31 December 2025.- New business sales were up 25 per cent to US$2.446 billion compared to 2024 on an annualised premium equivalent (APE) basis. New business contractual service margin (CSM) was US$1.476 billion, with year-on-year growth of 18 per cent.- Operating profit after tax was up five per cent to US$499 million with positive contributions from each of the company’s four geographic reporting segments – Hong Kong SAR & Macau SAR; Thailand & Cambodia; Japan; and Emerging Markets.- Net profit of US$166 million is a record IFRS 17 result and for the second consecutive year, FWD Group was operating cash flow positive as at 31 December 2025. Leverage ratio reduced to 21.3 per cent approaching the company’s target range of 15-20 per cent.- Significantly increased important indicators of shareholder value creation, with comprehensive tangible equity (CTE) up 18 per cent to US$8.72 billion compared to 31 December 2024 and Group embedded value (EV) up 19 per cent year-on-year to US$6.85 billion. A strong capital position was maintained with a 265 per cent solvency ratio^.- In December 2025, FWD Group was added to the Hang Seng Composite Index and the eligible securities list for the Stock Connect programme, where Mainland Chinese investors connect via the Shanghai Stock Exchange and Shenzhen Stock Exchange with Hong Kong market opportunities via a southbound trading mechanism. FWD Group was also included in the MSCI Hong Kong Small Cap Index in February 2026.Huynh Thanh Phong, Group Chief Executive Officer and Executive Director of FWD Group, said, “2025 was a stand-out year for FWD Group. We successfully executed our customer-led strategy, underpinned by our digitally enabled business model. Record financial results were achieved. And of course, we began trading as a publicly listed company, following our July 2025 initial public offering. This fulfilled a long-held objective to ensure FWD Group has full capital market access, as a solid foundation for our future development and growth.”The strong 2025 results were driven by organic growth across most of the 10 Asian markets where FWD Group operates, with a particularly outstanding performance in the Hong Kong SAR & Macau SAR segment.A solid performance was posted in Japan, in a year where FWD began to diversify beyond its successful protection business into the retirement and savings segment, with its first offering – a yen-denominated single premium variable annuity product.As an established market leader in Thailand, FWD remains well positioned to grow quality new business in future, despite headwinds from a lower rate environment which impacted 2025 results, in addition to the 2024 exit from underwriting new business in the corporate care segment.Excellent growth was delivered in the Emerging Markets segment – which is comprised of five of the rest of FWD Group’s Southeast Asian markets – consistent with the longer-term demographic, wealth creation, and digital adoption trends in this region.“With 2026 already underway, we remain firmly focused on executing our strategy as we build for the future – operating with customers at the heart of everything we do in high-growth Asian markets, with a focus on long-term sustainability and profitability,” added Huynh Thanh Phong.About FWD GroupFWD Group (1828.HK) is a pan-Asian life and health insurance business that serves more than 38 million customers across 10 markets, including BRI Life in Indonesia. FWD’s customer-led and tech-enabled approach aims to deliver innovative propositions, easy-to-understand products and a simpler insurance experience. Established in 2013, the company operates in some of the fastest-growing insurance markets in the world with a vision of changing the way people feel about insurance. FWD Group is listed on the main board of the Hong Kong Stock Exchange under the stock code 1828.For more information, please visit www.fwd.comFor media inquiries, please contact: groupcommunications@fwd.comSource: FWD Group Holdings LimitedThe results are for the 12 months ended 31 December 2025 and are compared to the same period in 2024.Group LCSM cover ratio, group embedded value, comprehensive tangible equity values are December 2025 balances/ratios and growth rates are represented accordingly.Growth rates are represented on a constant exchange rate (CER) basis, unless otherwise stated.Except for operating profit/(loss) after tax (non-IFRS measure), net profit/(loss), and comprehensive tangible equity, all other numbers are unaudited. Operating profit after tax and net profit after tax represent the amounts attributable to equity holders of the company and are presented net of non-controlling interests. New business sales are calculated on an annualised premium equivalent (APE) basis, based on 100 percent annualised first year premiums and 10 percent single premiums. Comprehensive tangible equity is calculated as total equity of the Group attributable to shareholders of the Company plus contractual service margin (net of tax and non-controlling interests), minus intangible assets (net of non-controlling interests).* Actual exchange rate basis ^ Prescribed capital requirement (PCR) basis Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
M3M3TIC 推出 Bonfire Terminal v2.7.1，一款由人工智能开发的自动化营销运营平台
(SeaPRwire) - 加利福尼亚州马里布 – 2026年3月16日 – (SeaPRwire) – 软件开发商M3M3TIC LLC宣布推出Bonfire Terminal v2.7.1，这是一款本地运行的软件平台，旨在自动化广泛的数字营销任务。该公司将此系统描述为一款由AI开发的应用程序，能够通过简单的自然语言指令生成营销内容、管理营销活动并发布材料。 据该公司介绍，这款软件主要由名为“AI Larry Ellison”的AI代理开发，生成的代码库超过4000行。最终的应用程序旨在生成网站、制作营销视频并部署数字广告，无需用户管理多个外部平台或服务。 营销工作流的本地执行 Bonfire Terminal完全运行在本地硬件上，而非云基础设施。该系统直接在用户设备上处理内容生成、视频渲染和活动管理等任务。这种架构消除了对订阅服务、云存储或第三方处理服务的需求。 该平台旨在帮助企业自动化传统上需要多个软件工具和专业人员的营销工作流。通过自然语言提示，用户可以指示系统创建宣传材料、编辑媒体资产并启动广告活动。 M3M3TIC LLC创始人John Crestani表示，其目标是通过自动化简化营销运营。 “许多营销团队依赖众多工具和平台，这可能造成显著的运营负担，”Crestani表示，“Bonfire Terminal的设计理念是开发一个能够自动生成并部署营销资产的系统，同时允许用户通过简单指令与其交互。” AI驱动的开发流程 Bonfire Terminal本身的开发反映了AI在软件工程中日益增长的作用。该公司称，负责该项目的AI代理使用包含Rust、Python、Go、Lua、Node.js和V的多语言软件栈构建了该应用程序。 系统架构包含一个持久化后台服务，旨在处理视频渲染、自动化工作流和广告集成等功能。这种设计使平台能够作为一个独立环境运行，无需外部依赖即可执行复杂任务。 根据AI代理对开发流程的描述，系统架构通过迭代提示和测试周期将产品需求转化为代码而创建。 AI辅助开发的新兴趋势 此次发布正值AI辅助软件开发关注度不断上升的时期。生成式AI工具的进步使开发者和创业者能够加速编码流程并更快速地原型化应用程序。 Bonfire Terminal被视为AI系统在人类指导下助力构建完整软件产品的范例。在此案例中，创始人定义了产品目标，而AI代理则跨越多种编程语言完成了具体实现。 该软件目前支持Windows平台（x64和ARM64），计划未来版本支持macOS。安装包包含所有必要组件，可在无互联网连接的情况下运行。 在AI自动化市场中的定位 除营销自动化外，该公司表示Bonfire Terminal可能在硬件编排和离线AI环境中具有更广泛的应用。该平台设计为在单一终端界面内支持本地大语言模型推理、语音交互和设备管理。 行业动态显示，本地AI处理和去中心化自动化系统的关注度正不断上升。近年来，多家消费和企业科技提供商已探索云依赖架构的替代方案，尤其针对敏感隐私应用。 可用性 Bonfire Terminal v2.7.1目前已开放购买，许可席位定价起于5000美元。 关于M3M3TIC LLC M3M3TIC LLC是一家专注于为设备连接和自动化构建离线AI系统的软件开发公司。由John Crestani创立，其旗舰产品Bonfire Terminal在单一软件平台内集成了本地AI推理、语音控制和设备编排功能。 该公司称，该产品的开发得到了人工智能系统的重大协助，并获得了Antler Ventures的支持。本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布，覆盖超过6,500个媒体库、86,000名编辑和记者，以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。